is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Mylan Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Mylan Inc. in the form of a SWOT analysis
An in-depth view of the business model of Mylan Inc. including a breakdown and examination of key business segments
Intelligence on Mylan Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Mylan Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Mylan (or 'the company') is a leading provider of generic pharmaceutical products. It also develops, licenses, manufactures, markets and distributes branded generic and specialty pharmaceuticals. The company primarily operates in North America and Europe. It is headquartered in Canonsburg, Pennsylvania, and employed more than 20,000 people as of December 31, 2013. The company recorded revenues of $6,909.1 million during the financial year ended December 2013 (FY2013), an increase of 1.7% over FY2012. The operating profit of the company was $1,135.5 million during FY2013, an increase of 2.4% over FY2012. The net profit was $623.7 million in FY2013, a decrease of 2.7% compared with FY2012.
Reasons to Purchase:
Gain understanding of Mylan Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Mylan Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Mylan Inc.’s business structure, strategy and prospects